Acumen Pharmaceuticals, Inc.

Basic Information

Acumen Pharmaceuticals, Inc.
385 Oyster Point Blvd.
South San Francisco, CA, 94080

Point of Contact Information

Field Value
Business Official:
Firm CFO (or equivalent):
POC Contracting Officer (or equivalent)

Additional Details

Field Value
SBC Control ID: SBC_000412536
DUNS: n/a
CAGE: n/a
SIC Codes: n/a
NAICS Codes: n/a

Company Profile


  1. Drug discovery of anti-ADDL therapeutics for Alzheimer's

    Amount: $183,750.00

    DESCRIPTION (provided by applicant): Recent evidence suggests that the primary cause of Alzheimer's disease is the progressive accumulation of neurotpxic oligomeric assemblies of the Abeta 1-42 prote ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Biomarker for Alzheimer's Related Cognitive Deficits

    Amount: $145,774.00

    DESCRIPTION (provided by applicant): The molecular and cellular details underlying Alzheimer's disease (AD) are being defined at an accelerating pace, leading to new therapeutic discovery efforts tha ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government